Veracyte to Present at Upcoming Investor Conferences

On June 2, 2021 Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, reported that Marc Stapley, chief executive officer, and Bonnie Anderson, executive chairwoman, are scheduled to participate in two upcoming virtual investor conferences (Press release, Veracyte, JUN 2, 2021, View Source [SID1234583396]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs 42nd Annual Global Healthcare Conference
Fireside chat on Wednesday, June 9, 2021, at 9:40 a.m. Eastern Time
Raymond James Human Health Innovation Conference
Fireside chat on Wednesday, June 23, 2021, at 2:40 p.m. Eastern Time
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at View Source Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.